Andreas Billich

Person

Moedlin, AT

People

Patents Grantslast 30 patents

Information Patent Grant
aSMase inhibitors
- Patent number 8,119,617
- Issue date Feb 21, 2012
- Novartis AG
- Karl Baumann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazine derivatives and their use as therapeutic agents
- Patent number 7,964,591
- Issue date Jun 21, 2011
- Novartis Pharma AG
- Andreas Billich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-dihydro-benzo[e][1,3]oxazin-2-ones
- Patent number 7,795,251
- Issue date Sep 14, 2010
- Novartis AG
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazine derivatives and their use as therapeutic agents
- Patent number 7,759,348
- Issue date Jul 20, 2010
- Xenon Pharmaceuticals Inc.
- Andreas Billich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MIF-inhibitors
- Patent number 7,378,416
- Issue date May 27, 2008
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzoxa- and benzthiazoles
- Patent number 6,716,865
- Issue date Apr 6, 2004
- Novartis AG
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chromanone and thiochromanone compounds
- Patent number 6,346,626
- Issue date Feb 12, 2002
- Novartis AG
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-diamino-3-hydroxycarboxylic acid derivatives
- Patent number 5,538,997
- Issue date Jul 23, 1996
- Sandoz Ltd.
- Andreas Billich
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Combinations Comprising a VEGF Receptor Inhibitor
- Publication number 20120172386
- Publication date Jul 5, 2012
- Novartis AG
- Andreas BILLICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE T...
- Publication number 20110021530
- Publication date Jan 27, 2011
- Xenon Pharmaceuticals Inc.
- Andreas Billich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biomarker in Inflammatory Diseases
- Publication number 20100029007
- Publication date Feb 4, 2010
- NOVAARTIS AG
- Thomas Baumruken
- G01 - MEASURING TESTING
Information Patent Application
aSMase inhibitors
- Publication number 20100022482
- Publication date Jan 28, 2010
- Karl Baumann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES
- Publication number 20090156588
- Publication date Jun 18, 2009
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fluorescent Labeled Sphingosines
- Publication number 20080318255
- Publication date Dec 25, 2008
- Andreas Billich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATME...
- Publication number 20080139551
- Publication date Jun 12, 2008
- Avanir Pharmaceuticals
- Jagadish Sircar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MIF-INHIBITORS
- Publication number 20070219189
- Publication date Sep 20, 2007
- Andreas Billich
- C07 - ORGANIC CHEMISTRY

Andreas Billich

Person

Patents Grantslast 30 patents

aSMase inhibitors

Pyridazine derivatives and their use as therapeutic agents

3,4-dihydro-benzo[e][1,3]oxazin-2-ones

Pyridazine derivatives and their use as therapeutic agents

MIF-inhibitors

Benzoxa- and benzthiazoles

Chromanone and thiochromanone compounds

2,4-diamino-3-hydroxycarboxylic acid derivatives

Patents Applicationslast 30 patents

Combinations Comprising a VEGF Receptor Inhibitor

PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE T...

Biomarker in Inflammatory Diseases

aSMase inhibitors

3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES

Fluorescent Labeled Sphingosines

TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATME...

MIF-INHIBITORS